Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10914590 | Molecular Oncology | 2014 | 14 Pages |
Abstract
An important step towards personalizing antibody treatment could be the implementation of theranostics. Antibody theranostics combine the diagnostic and therapeutic potential of an antibody, thereby selecting those patients who are most likely to benefit from antibody treatment. This review focuses on the clinical application of theranostic antibodies in oncology. It provides detailed information concerning the suitability of antibodies for theranostics, the different types of theranostic tests available and summarizes the efficacy of theranostic antibodies used in current clinical practice. Advanced theranostic applications, including radiolabeled antibodies for non-invasive functional imagining, are also addressed. Finally, we discuss the importance of theranostics in the emerging field of personalized medicine and critically evaluate recent data to determine the best way to apply antibody theranostics in the future.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Emmy D.G. Fleuren, Yvonne M.H. Versleijen-Jonkers, Sandra Heskamp, Carla M.L. van Herpen, Wim J.G. Oyen, Winette T.A. van der Graaf, Otto C. Boerman,